Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Minutes of meetings

Beirut
2018 2019
MoM-MHPSS TF-Beirut-Nov18
MoM-MHPSS TF-Beirut-Oct18
MoM-MHPSS TF-Beirut-Sep18
MoM-MHPSS TF-Beirut-Aug18
MoM-MHPSS TF-Beirut-July18

MoM-MHPSS TF-Beirut-Apr19
MoM-MHPSS TF-Beirut-Mar19
MoM-MHPSS TF-Beirut-Feb19
MoM-MHPSS TF-Beirut-Jan19

 
2016 2017
MoM-MHPSS TF-Beirut-26-Nov16
MoM-MHPSS TF-Beirut-25-Oct16
MoM-MHPSS TF-Beirut-24-Sep16
MoM-MHPSS TF-Beirut-23-Aug16
MoM-MHPSS TF-Beirut-22-July16
MoM-MHPSS TF-Beirut-20-Apr16
MoM-MHPSS TF-Beirut-19-Mar16
MoM-MHPSS TF-Beirut-18-Feb16
MoM-MHPSS TF-Beirut-17-Jan16
MoM-MHPSS TF-Beirut-9-May17
MoM-MHPSS TF-Beirut-31-July17
MoM-MHPSS TF-Beirut-12-Sep17
MoM-MHPSS TF-Beirut-14-Nov17

Bekaa
2018 2019
MoM-MHPSS TF-Bekaa-Nov18
MoM-MHPSS TF-Bekaa-Oct18
MoM-MHPSS TF-Bekaa-​Sep18
MoM-MHPSS TF-Bekaa-Aug18
MoM-MHPSS TF-Bekaa-July18
MoM-MHPSS TF-Bekaa-June18
MoM-MHPSS TF-Bekaa-Apr19
MoM-MHPSS TF-Bekaa-Mar19
MoM-MHPSS TF-Bekaa-Feb19
MoM-MHPSS TF-Bekaa-Jan19
 
2016 2017
MoM-MHPSS TF-Bekaa-20-Dec16
MoM-MHPSS TF-Bekaa-25-Oct16
MoM-MHPSS TF-Bekaa-27-Sep16
MoM-MHPSS TF-Bekaa-01-May16

MoM-MHPSS TF-Bekaa-28 Feb17
MoM-MHPSS TF-Bekaa-24-Jan17
 

North
2018 2019
MoM-MHPSS TF-North-Nov18
MoM-MHPSS TF-North-Oct18
MoM-MHPSS TF-North-​Sep18
MoM-MHPSS TF-North-Aug18
MoM-MHPSS TF-North-July18
MoM-MHPSS TF-North-Apr19
MoM-MHPSS TF-North-Mar19
MoM-MHPSS TF-North-Feb19
MoM-MHPSS TF-North-Jan19
 
2015 2016
MoM-MHPSS TF-North-1-Aug15
MoM-MHPSS TF-North-2-Sept15
MoM-MHPSS TF-North-3-Oct15
MoM-MHPSS TF-North-4-Nov15
MoM-MHPSS TF-North-5-Dec15
MoM-MHPSS TF-North-14-Nov16
MoM-MHPSS TF-North-13-Oct16
MoM-MHPSS TF-North-12-Aug16
MoM-MHPSS TF-North-10-June16
MoM-MHPSS TF-North-9-May16
MoM-MHPSS TF-North-8-Mar16
MoM-MHPSS TF-North-7-Feb16
MoM-MHPSS TF-North-6-Jan16

South
2018 2019
MoM-MHPSS TF-South-Nov18
MoM-MHPSS TF-South-Oct18
MoM-MHPSS TF-South-​Sep18
MoM-MHPSS TF-South-Aug18
MoM-MHPSS TF-South-July18
MoM-MHPSS TF-South-Apr19
MoM-MHPSS TF-South-Mar19
MoM-MHPSS TF-South-Feb19
MoM-MHPSS TF-South-Jan19

2015 2016
MoM-MHPSS TF-South-5-Dec15
MoM-MHPSS TF-South-4-Nov15
MoM-MHPSS TF-South-3-Oct15
MoM-MHPSS TF-South-2-Sep15
MoM-MHPSS TF-South-1-Aug15
 
MoM-MHPSS TF-South-12-Oct16
MoM-MHPSS TF-South-11-Aug16
MoM-MHPSS TF-South-10-June16
MoM-MHPSS TF-South-9-May16
MoM-MHPSS TF-South-8-March16
MoM-MHPSS TF-South-7-Feb16
MoM-MHPSS TF-South-6-Jan16
 
 
 
 
 


 
    2
ATC Name B/G Ingredients Dosage Form Price
B02BX06 HEMLIBRA BioTech Emicizumab - 150mg/ml 150mg/ml Injectable solution 895,547,224 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 105mg/0.7ml 105mg/0.7ml Injectable solution 722,177,054 L.L
A10AB01 HUMULIN R U-100 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable solution 701,486 L.L
A10AB04 HUMALOG KWIKPEN BioTech Insulin lispro - 100IU/ml 100IU/ml Injectable solution 3,950,897 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose 0.5ml/dose Injectable suspension 1,777,904 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose 0.5ml/dose Injectable suspension 2,257,655 L.L
A10AB04 HUMALOG BioTech Insulin lispro - 100IU/ml 100IU/ml Injectable suspension 1,988,887 L.L
A10AD01 HUMULIN 70/30 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 701,486 L.L
A10AD04 HUMALOG MIX 50 KWIKPEN BioTech Insulin lispro solution - 50%, Insulin lispro protamine suspension - 50% 100IU/ml Injectable suspension 3,950,897 L.L
A10AD04 HUMALOG MIX 25 KWIKPEN BioTech Insulin lispro solution - 25%, Insulin lispro protamine suspension - 75% 100IU/ml Injectable suspension 3,950,897 L.L
A10AE01 HUMULIN N U-100 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 701,486 L.L
J07CA09 HEXAXIM BioTech Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg Injectable suspension 4,462,901 L.L
H01AC01 HHT BioTech Somatropin recombinant - 16IU (5.32mg) 16IU (5.32mg) Injectable freeze dried powder + diluent 4,078,562 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 4,000IU 4,000IU Injectable freeze dried substance+diluent 940,690 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 4,000IU 4,000IU Injectable freeze dried substance+diluent 33,852,747 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 10,000IU 10,000IU Injectable freeze dried substance+diluent 2,687,685 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 20,000IU 20,000IU Injectable freeze dried powder + diluent 5,438,531 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 40,000IU 40,000IU Injectable freeze dried powder + diluent 6,316,060 L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 440mg 440mg Injectable powder for concentrate for solution 82,195,925 L.L
B01AB05 HEPAXANE 4000IU BioTech Enoxaparin sodium - 40mg/0.4ml 40mg/0.4ml Injectable solution 3,559,839 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 150mg 150mg Injectable powder for concentrate for solution 36,113,036 L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 34,045,375 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 28,611,772 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 28,611,772 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 52,871,023 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 52,871,023 L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution L.L
    2
Sitemap
© Copyrights reserved to Ministry of Public Health 2025